The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
CRISPR screens identify gene targets at breast cancer risk loci
Open accessAbstract
Background: Genome-wide association studies (GWAS) have identified > 200 loci associated with breast cancer risk. The majority of candidate causal variants are in non-coding regions and likely modulate cancer risk by regulating gene expression. However, pinpointing the exact target of the association, and identifying the phenotype it mediates, is a major challenge in the interpretation and translation of GWAS. Results: Here, we show that pooled CRISPR screens are highly effective at identifying GWAS target genes and defining the cancer phenotypes they mediate. Following CRISPR mediated gene activation or suppression, we measure proliferation in 2D, 3D, and in immune-deficient mice, as well as the effect on DNA repair. We perform 60 CRISPR screens and identify 20 genes predicted with high confidence to be GWAS targets that promote cancer by driving proliferation or modulating the DNA damage response in breast cells. We validate the regulation of a subset of these genes by breast cancer risk variants. Conclusions: We demonstrate that phenotypic CRISPR screens can accurately pinpoint the gene target of a risk locus. In addition to defining gene targets of risk loci associated with increased breast cancer risk, we provide a platform for identifying gene targets and phenotypes mediated by risk variants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 CRISPR activation and suppression screens identify BC risk genes that regulate proliferation in 2D, 3D. A Pie chart showing locations of CCVs at 205 BC risk signals identified by GWAS. B Classes of genes selected for functional CRISPR screens. INQ_1 – high-confidence INQUISIT predictions; INQ_2—moderate-confidence INQUISIT predictions; TWAS – identified by transcriptome wide association studies and eQTL studies. C Experimental approach. D Summary of results from 2 and 3D proliferation screens. Known driver gene annotations were from [3]](/paper-figures/57c884ed4ed546bc877838da5ec9eee3/crispr-screens-identify-gene-targets-at-breast-cancer-risk-loci-figure-1.jpg)

![Fig. 3 Olaparib synthetic lethal screens identify BC-risk genes that regulate the DNA repair pathway. A Experimental approach. B B80-T5 cells infected with control or BRCA1-targeting sgRNAs were treated with olaparib for 7 days. C Summary of hits. Known DNA repair genes were annotated based on [33]. D GSEA pathway enrichment analysis of hits (not including background positive control genes). E Validation of selected hits in a singleton experiment using a crystal violet readout. F Enrichment of genes predicted by various computational and statistical methods among the combined hits from all phenotypic screens. INQ_1—high-confidence INQUISIT predictions (genes scored as INQ_1 due to their driver status were downgraded to INQ_2 for this analysis); INQ_2—moderate-confidence INQUISIT predictions; TWAS—identified by transcriptome wide association studies or eQTL studies](/paper-figures/03bd054b7a8e4b4d8b86c99ecf6a6359/crispr-screens-identify-gene-targets-at-breast-cancer-risk-loci-figure-3.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 1×
“Impaired proliferation is a hallmark of cancer [13].”
BackgroundPD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672 · cited 2×
“Expression and ATAC-Seq profiling indicated that these six cell lines represent breast cells with either a luminal progenitor signature (K5 + /K19 + [17], K5 + /K19 − [17]), a mesenchymal signature (B80-T17 [18], mesHMLE [19]), or a more epithelial like signature (B80-T5 [18], HMLE [20]) (Additional file 1: Fig.”
BackgroundMassively parallel digital transcriptional profiling of single cells
Zheng, G. X. Y., Terry, J. M., Belgrader, P., Ryvkin, P., Bent, Z. W., Wilson, R., Ziraldo, S. B., Wheeler, T. D., McDermott, G. P., Zhu, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14049 · Cited by 7,353
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3437 · Cited by 4,637 · cited 3×
“sgRNAs were designed using CRISPick algorithm [14].”
MethodInfluentialATAC-seq: a method for assaying chromatin accessibility genome-wide
Buenrostro, J. D., Wu, B., Chang, H. Y., & Greenleaf, W. J. (2015) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb2129s109 · Cited by 3,289
Li, W., Xu, H., Xiao, T., Cong, L., Love, M. I., Zhang, F., Irizarry, R. A., Liu, J. S., Brown, M., & Liu, X. S. (2014) · Genome Biology · doi:10.1186/s13059-014-0554-4 · Cited by 2,684
Comprehensive Characterization of Cancer Driver Genes and Mutations
Bailey, M. H., Tokheim, C., Porta-Pardo, E., Sengupta, S., Bertrand, D., Weerasinghe, A., Colaprico, A., Wendl, M. C., Kim, J., Reardon, B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.060 · Cited by 2,256
Research works printed but not linked: 1
- Tuano NK, Beesley J, Manning M, Shi W, Perlaza-Jimenez L, Malaver-Ortega LF, Paynter J, Black D, Civitarese A, McCue K, Hatzipantelis A, Hillman K, Kaufmann S, Sivakumaran H, Polo JM, Reddel R, Vimla B, French JD, Edwards SL, Powell D, Chenevix-Trench G, Rosenbluh J. CRISPR screens identify gene targets at breast cancer risk loci. Gene Expression Omnibus (GSE219168) 2023; https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE219168.
Cited by
Wang, L., Bitar, M., Lu, X. M., Jacquelin, S., Nair, S., Sivakumaran, H., Hillman, K. M., Kaufmann, S., Ziegman, R., Casciello, F., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02021-y · Cited by 30
“…set included, (i) the 844 breast cancer-associated lncRNAs we previously linked with GWAS risk variants [7]; (ii) 59 annotated lncRNAs; and (iii) 935 protein-coding genes, including (with overlap) 129 estrogen-regulated genes [13], 246 breast cancer driver genes [14] and 612 essential genes [14].”
BackgroundSelf-citationBarry, T., Mason, K., Roeder, K., & Katsevich, E. (2024) · Genome Biology · doi:10.1186/s13059-024-03254-2 · Cited by 28
“For example, two recent studies lever-aged high-MOI single-cell screens to perturb blood disease [11] and cancer [35] GWAS variants (in some cases at single nucleotide resolution) and link these variants to target genes in disease-relevant cell types (both studies used SCEPTRE (high-MOI) to analyze…”
Innovating cancer drug discovery with refined phenotypic screens
Wang, Z., Hulíková, A., & Swietach, P. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.06.001 · Cited by 23
Identification of resistance mechanisms to small-molecule inhibition of TEAD-regulated transcription
Kulkarni, A., Mohan, V., Tang, T. T.-L., Post, L. E., Chan, Y.-C., Manning, M., Thio, N., Parker, B. L., Dawson, M. A., Rosenbluh, J., et al. (2024) · EMBO Reports · doi:10.1038/s44319-024-00217-3 · Cited by 22
“Sequencing libraries were generated using one-step PCR to amplify the integrated sequence within the construct and the addition of a sample barcode and Illumina adapters as previously described (Tuano et al, 2023).”
MethodSelf-citationEnhancer regulatory networks globally connect non-coding breast cancer loci to cancer genes
Wang, Y., Armendariz, D. A., Wang, L., Zhao, H., Xie, S., & Hon, G. C. (2025) · Genome biology · doi:10.1186/s13059-025-03474-0 · Cited by 16
Metadata
- Authors
- Tuano, N. K., Beesley, J., Manning, M., Shi, W., Perlaza-Jimenez, L., Malaver-Ortega, L. F., Paynter, J. M., Black, D., Civitarese, A., McCue, K., Hatzipantelis, A., Hillman, K., Kaufmann, S., Sivakumaran, H., Polo, J. M., Reddel, R. R., Band, V., French, J. D., Edwards, S. L., Powell, D. R., Chenevix-Trench, G., & Rosenbluh, J.
- Affiliations
- Monash University (AU)
- QIMR Berghofer Medical Research Institute (AU)
- The University of Sydney (AU)
- University of Nebraska Medical Center (US)
- Corresponding author
- Rosenbluh, Joseph
- ORCID
- Venue
- Genome Biology
- Published
- 2023-03-29
- Volume
- 24
- Issue
- 1
- Pages
- 59-59
- ISSN
- 1465-6906 (ISSN-L)
- 1474-760X
- PMC
- PMC10053147
- OpenAlex
- W4361199386
- Cited by
- 30
- References
- 77
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 14 · 2023: 4
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Genome biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Health and Medical Research Council (1194914, 1135932)
- DoD (W81XWH1910116)
- Victorian Cancer Agency (MCRF20035)
- Isabel and Roderic Allpass
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- CRISPR screen, cell proliferation, DNA damage response, DNA repair, non-coding variants, causal variants, 3D cell culture, immunodeficient mice
- MeSH terms
- Animals, Neoplasms, Phenotype, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Mice, Genome-Wide Association Study, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CRISPR screens identify gene targets at breast cancer risk loci. https://app.cochat.ai/papers/10.1186/s13059-023-02898-w
- The paper
- Tuano, N. K., Beesley, J., Manning, M., Shi, W., Perlaza-Jimenez, L., Malaver-Ortega, L. F., Paynter, J. M., Black, D., Civitarese, A., McCue, K., Hatzipantelis, A., Hillman, K., Kaufmann, S., Sivakumaran, H., Polo, J. M., Reddel, R. R., Band, V., French, J. D., Edwards, S. L., . . . Rosenbluh, J. (2023). CRISPR screens identify gene targets at breast cancer risk loci. Genome Biology. https://doi.org/10.1186/s13059-023-02898-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.